EVP, Investments & GC of Nektar Therapeutics (NASDAQ:NKTR), Chess Robert, sells 8,000 shares worth $151,840
According to Nektar Therapeutics's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 16 06:02 PM, company EVP, Investments & GC, Chess Robert disclosed selling 8,000 shares at a cost of $18.98. At the time of this transaction (Apr 14), this trade was worth $151,840 in total. As of Apr 14, Chess Robert now owns 280,573 shares in total worth about $5,330,887.0.
For the last few recent trades made by Nektar Therapeutics (NASDAQ:NKTR) EVP, Investments & GC, Chess Robert, we have the following information:
- SEC Form 4 filing: Sep 25: Sold 5,500 shares at the rate of $17.75 per share. Total worth of this trade was $97,625. Total number of shares owned as of Sep 25 were 280,573
- SEC Form 4 filing: Sep 27: Sold 4,000 shares at the rate of $17.99 per share. Total worth of this trade was $71,960. Total number of shares owned as of Sep 27 were 276,973
- SEC Form 4 filing: Sep 19: Sold 4,500 shares at the rate of $56.81 per share. Total worth of this trade was $255,645. Total number of shares owned as of Sep 19 were 269,723
Posted by
George Daniels
on Saturday April 17 2021, 2:47 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
